Pancreatic Cancer Cells Invasiveness is Mainly Affected by Interleukin-1β not by Transforming Growth Factor-β1
暂无分享,去创建一个
M. Plebani | S. Pedrazzoli | C. Zambon | F. Navaglia | D. Basso | E. Greco | P. Fogar | E. Ancona | A. Falda | S. Mazza
[1] B. Sipos,et al. Tumor Stroma Interactions Induce Chemoresistance in Pancreatic Ductal Carcinoma Cells Involving Increased Secretion and Paracrine Effects of Nitric Oxide and Interleukin-1β , 2004, Cancer Research.
[2] 松尾 洋一. Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential , 2004 .
[3] M. Plebani,et al. Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[4] H. Sawai,et al. Interleukin-1α Enhances Integrin α6β1 Expression and Metastatic Capability of Human Pancreatic Cancer , 2003, Oncology.
[5] M. Löhr,et al. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform , 2003, Virchows Archiv.
[6] M. Höglund,et al. Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFB1 , 2003, Genes, chromosomes & cancer.
[7] Y. Iwakura,et al. IL-1 is required for tumor invasiveness and angiogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[8] H. Sawai,et al. Enhancement of integrins by interleukin‐1α, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells , 2003, Journal of surgical oncology.
[9] K. Venkatasubbarao,et al. Rap1 reverses transcriptional repression of TGF‐β type II receptor by a mechanism involving AP‐1 in the human pancreatic cancer cell line, UK Pan‐1 , 2003, Journal of cellular physiology.
[10] Leif E. Peterson,et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection , 2002 .
[11] M. Rugge,et al. Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. , 2002, Cytokine.
[12] L. Wakefield,et al. TGF-β signaling: positive and negative effects on tumorigenesis , 2002 .
[13] F. Liu. SMAD4/DPC4 and pancreatic cancer survival. Commentary re: M. Tascilar et al., The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res., 7: 4115-4121, 2001. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] C. Hill,et al. Loss of Smad4 Function in Pancreatic Tumors , 2001, The Journal of Biological Chemistry.
[15] M. Ohira,et al. TGF-beta1 promotes liver metastasis of pancreatic cancer by modulating the capacity of cellular invasion. , 2001, International journal of oncology.
[16] Allan Balmain,et al. TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.
[17] T. Gress,et al. TGF‐β–induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase‐2 and the urokinase plasminogen activator system , 2001, International journal of cancer.
[18] B. Nicke,et al. Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells. , 2001, American journal of physiology. Cell physiology.
[19] B Johansson,et al. Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas. , 2001, International journal of oncology.
[20] A. Balmain,et al. TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.
[21] J. Massagué,et al. How cells read TGF-β signals , 2000, Nature Reviews Molecular Cell Biology.
[22] O. Volpert,et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Wells,et al. Tumor invasion: role of growth factor-induced cell motility. , 2000, Advances in cancer research.
[24] J. Massagué. How cells read TGF-beta signals. , 2000, Nature reviews. Molecular cell biology.
[25] M. Plebani,et al. Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. , 1999, Pancreas.
[26] T. Gress,et al. Invasion and metastasis in pancreatic cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] R. Hruban,et al. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. , 1998, Cancer research.
[28] D. Berger,et al. The Effect of Thrombospondin-1 and TGF-β1 on Pancreatic Cancer Cell Invasion , 1998 .
[29] M. Pepper,et al. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. , 1997, Cytokine & growth factor reviews.
[30] M. Plebani,et al. Insulin-like growth factor-I, interleukin-1 α and β in pancreatic cancer: role in tumor invasiveness and associated diabetes , 1995 .
[31] M. Plebani,et al. Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes. , 1995, International journal of clinical & laboratory research.
[32] Brooks Jw,et al. Interleukin-1 signal transduction. , 1994 .
[33] C. Dinarello,et al. The biological properties of interleukin-1. , 1994, European cytokine network.
[34] C. Dinarello,et al. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. , 1994, Cancer research.
[35] H. Friess,et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival , 1993 .
[36] R. L. Baldwin,et al. Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. , 1993, Growth factors.
[37] F. Breviario,et al. Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. , 1988, The Journal of clinical investigation.
[38] Y Iwamoto,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.